Chantix Recall Expanded To U.S. Products Due To N-Nitroso Varenicline Contamination
Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.…
«
»
Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.…
Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.…
The FDA has delayed an expanded approval for the drug Jakafi, potentially due to concerns over heart and cancer risks linked to Pfizer’s Xeljanz, a similar drug.…
Side effects of the rheumatoid arthritis and ulcerative colitis drug Xeljanz may result in the development of serious and potentially lethal pulmonary embolism. Lawsuits are being reviewed by lawyers nationwide.…
Some believe the FDA is preparing to review the risks and benefits of Xeljanz and similar drugs given recent cancer and heart concerns.…
Growing concerns have led to Health Canada announcing a Xeljanz safety review, to determine whether more warnings or actions are needed following studies suggesting the ulcerative colitis drug could increase the risk of cancer and heart attacks.…
New Xeljanz research links the drug to cancer risks, but has not yet led to a warning for users as to which types of cancer they may face.…
The first bellwether trial for claims of Nexium, Prevacid and Prilosec kidney damages is slated to begin in January 2022.…
Pfizer filed a patent lawsuit over an alleged attempt to create a generic version of Xeljanz shortly after the FDA announced new concerns about the drug’s safety.…
The FDA is weighing new restrictions on Xeljanz, following clinical trial data linking the drug to an increased risk of heart problems and cancer, according to a new report.…